Trials / Completed
CompletedNCT00910312
ICE-SENSE™ Cryotherapy for Breast Fibroadenoma Trial
Evaluation of Safety and Feasibility of the ICE-SENSE™, a Cryotherapy Device for Office-based Ultrasound-guided Treatment of Breast Fibroadenoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- IceCure Medical Ltd. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the Ice-Sense, a novel cryotherapy system (a system that freezes tissues), is safe and effective in the treatment of benign breast tumors such as fibroadenoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ice-Sense | Ice-Sense Cryoprobe |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2009-05-29
- Last updated
- 2022-08-17
Locations
4 sites across 3 countries: Czechia, Germany, Israel
Source: ClinicalTrials.gov record NCT00910312. Inclusion in this directory is not an endorsement.